Meta-analysis: Proton-pump inhibition in high-risk patients with acute peptic ulcer bleeding

Alimentary Pharmacology and Therapeutics

Volumn 21, Issue 6, 2005, Pages 677-686

  Bardou, M ^a,b   Toubouti, Y ^a   Benhaberou Brun, D ^a   Rahme, E ^a   Barkun, A N ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OCTREOTIDE; OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RANITIDINE; SOMATOSTATIN;

ACUTE DISEASE; AGE; ARTICLE; CAUSE OF DEATH; CLINICAL TRIAL; DRUG EFFICACY; DRUG MEGADOSE; ENDOSCOPIC THERAPY; HEMOSTASIS; HIGH RISK PATIENT; HUMAN; MEDLINE; META ANALYSIS; MORTALITY; PEPTIC ULCER; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; RECURRENT DISEASE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFUSIONS, INTRAVENOUS; PEPTIC ULCER HEMORRHAGE; PROTON PUMPS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 16344382216     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02391.x     Document Type: Article

References (63)

1. Gilbert DA. Epidemiology of upper gastrointestinal bleeding. Gastrointest Endosc 1990; 36: S8-13.
2. Cutler JA; Mendeloff AI. Upper gastrointestinal bleeding. Nature and magnitude of the problem in the US. Dig Dis Sci 1981; 26: 90S-6S.
3. Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol 1995; 90: 206-10.
4. Longstreth GF. Epidemiology and outcome of patients hospitalized with acute lower gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol 1997; 92: 419-24.
5. Silverstein FE, Gilbert DA, Tedesco FJ, Buenger NK, Persing J. The national ASGE survey on upper gastrointestinal bleeding: II. Clinical prognostic factors. Gastrointest Endosc 1981; 27: 80-93.
6. Brullet E, Campo R, Bedos G, Barcons S, Gubern JM, Bordas JM. Site and size of bleeding peptic ulcer. Is there any relation to the efficacy of hemostatic sclerotherapy? Endoscopy 1991; 23: 73-5.
7. Barkun A, Sabbah S, Enns R, et al. The Canadian registry on non-variceal upper gastrointestinal bleeding and endoscopy (RUGBE): endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real life setting. Am J Gastroenterol 2004; 99: 1238-46.
8. Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med 1994; 331: 717-27.
9. Arlt GD, Leyh M. Incidence and pathophysiology of peptic ulcer bleeding. Langenbecks Arch Surg 2001; 386: 75-81.
10. Barkun A, Bardou M, Marshall JK. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2003; 139: 843-57.
11. Higham J, Kang JY, Majeed A. Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of haemorrhage among older subjects. Gut 2002; 50: 460-4.
12. Paimela H, Paimela L, Myllykangas-Luosujarvi R, Kivilaakso E. Current features of peptic ulcer disease in Finland: incidence of surgery, hospital admissions and mortality for the disease during the past twenty-five years. Scand J Gastroenterol 2002; 37: 399-403.
13. van Leerdam M, Vreeburg E, Rauws E, et al. Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. Am J Gastroenterol 2003; 98: 1494-9.
14. Sacks HS, Chalmers TC, Blum AL, Berrier J, Pagano D. Endoscopic hemostasis. An effective therapy for bleeding peptic ulcers. JAMA 1990; 264: 494-9.
15. Cook DJ, Guyatt GH, Salena BJ, Laine LA. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis, Gastroenterology 1992; 102: 139-48.
16. Barkun AN, Cockeram AW, Plourde V, Fedorak RN. Review article: Acid suppression in non-variceal acute upper gastrointestinal bleeding. Aliment Pharmacol Ther 1999; 13: 1565-84.
17. Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet 1974; 2: 394-7.
18. Rockall TA, Logan RF, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996; 38: 316-21.
19. Romagnuolo J, Bardou M, Rahme E, Joseph L, Reinhold C, Barkun AN. Magnetic resonance cholangiopancreatography: a meta-analysis of test performance in suspected biliary disease. Ann Intern Med 2003; 139: 547-57.
20. Barkun AN. The role of intravenous proton pump inhibitors in the modern management of nonvariceal upper gastrointestinal bleeding. Drugs Today (Barc) 2003; 39 (Suppl. A): 3-10.
21. Sinclair J, Bracken M. Clinically useful measures of effect in binary analyses of randomized trials. J Clin Epidemiol 1994; 47: 881-9.
22. D'Amico G, Pietrosi G, Tarantino I, Pagliaro L. Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. Gastroenterology 2003; 124: 1277-91.
23. Sheu CF, Suzuki S. Meta-analysis using linear mixed models. Behav Res Methods Instrum Comput 2001; 33: 102-7.
24. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
25. Stram D. Meta-analysis of published data using a linear mixed-effects model. Biometrics 1996; 52: 536-44.
26. Poynard T, Lemaire M, Agostini H. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer. Eur J Gastroenterol Hepatol 1995; 7: 661-5.
27. Rauws EA, Kool G, Bolwerk C. New approaches to endoscopic therapy for a haemostasis upper GI bleed. Scand J Gastroenterol Suppl 1996; 218: 116-23.
28. Selby NM, Kubba AK, Hawkey CJ. Acid suppression in peptic ulcer haemorrhage: a 'meta-analysis'. Aliment Pharmacol Ther 2000; 14: 1119-26.
29. Savides TJ, Jensen DM. Therapeutic endoscopy for nonvariceal gastrointestinal bleeding. Gastroenterol Clin North Am 2000; 29: 465-87 (vii).
30. Yacyshyn BR, Thomson AB. Critical review of acid suppression in nonvariceal, acute, upper gastrointestinal bleeding. Dig Dis 2000; 18: 117-28.
31. Chak A, Cooper GS, Lloyd LE, Kolz CS, Barnhart BA, Wong RC. Effectiveness of endoscopy in patients admitted to the intensive care unit with upper GI hemorrhage. Gastrointest Endosc 2001; 53: 6-13.
32. Levine JE, Leontiadis GI, Sharma VK, Howden CW. Meta-analysis: the efficacy of intravenous H2-receptor antagonists in bleeding peptic ulcer. Aliment Pharmacol Ther 2002; 16: 1137-42.
33. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUORUM statement. QUOROM Group. Br J Surg 2000; 87: 1448-54.
34. Goletti O, Sidoti F, Lippolis PV, De Negri F, Cavina E. Omeprazole versus ranitidine plus somatostatin in the treatment of severe gastroduodenal bleeding: a prospective, randomized, controlled trial. Ital J Gastroenterol 1994; 26: 72-4.
35. Hasselgren G, Lind T, Lundell L, et al. Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study. Scand J Gastroenterol 1997; 32: 328-33.
36. Lau JY, Sung JJ, Lee KK, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000; 343: 310-6.
37. Lin HJ, Lo WC, Lee FY, Perng CL, Tseng GY. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med 1998; 158: 54-8.
38. Udd M, Miettinen P, Palmu A, et al. Regular-dose versus high-dose omeprazole in peptic ulcer bleeding: a prospective randomized double-blind study. Scand J Gastroenterol 2001; 36: 1332-8.
39. Schaffalitzky de Muckadell OB, Havelund T, Harling H, et al. Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study. Scand J Gastroenterol 1997; 32: 320-7.
40. Coraggio F, Rotondano G, Marmo R, et al. Somatostatin in the prevention of recurrent bleeding after endoscopic haemostasis of peptic ulcer haemorrhage: a preliminary report. Eur J Gastroenterol Hepatol 1998; 10: 673-6.
41. Javid G, Masoodi I, Zargar SA, et al. Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer. Am J Med 2001; 111: 280-4.
42. Kaviani MJ, Hashemi MR, Kazemifar AR, et al. Effect of oral omeprazole in reducing re-bleeding in bleeding peptic ulcers: a prospective, double-blind, randomized, clinical trial. Aliment Pharmacol Ther 2003; 17: 211-6.
43. Michel P, Duhamel C, Bazin B, et al. Lansoprazole versus ranitidine in the prevention of early recurrences of digestive hemorrhages from gastroduodenal ulcers. Randomized double-blind multicenter study. Gastroenterol Clin Biol 1994; 18: 1102-5.
44. Khuroo MS, Yattoo GN, Javid G, et al. A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med 1997; 336: 1054-8.
45. Bour B, Pariente EA, Hamelin B, Garcia E. Orally administered omeprazole versus injection therapy in the prevention of rebleeding from peptic ulcer with visible vessel. A multicenter randomized study. Gastroenterol Clin Biol 1993; 17: 329-33.
46. Bleau BL, Gostout CJ, Sherman KE, et al. Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy. Gastrointest Endosc 2002; 56: 1-6.
47. Chua RT, Lin HJ, Wang K, et al. Intravenous omeprazole prevents rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized controlled study. Chung Hua I Hsueh Tsa Chih (Taipei) 1996; 57: 139-45.
48. Cardi M, Muttillo IA, Amadori L, et al. Intravenous omeprazole versus ranitidine in the treatment of hemorrhagic duodenal ulcer: a prospective randomized study. Ann Chir 1997; 51: 136-9.
49. Grosso C, Rossi A, Gambitta P, et al. Non-bleeding visible vessel treatment: perendoscopic injection therapy versus omeprazole infusion. Scand J Gastroenterol 1995; 30: 872-5.
50. Jensen DM, Kovacs TO, Jutabha R, et al. Randomized trial of medical or endoscopic therapy to prevent recurrent ulcer hemorrhage in patients with adherent clots. Gastroenterology 2002; 123: 407-13.
51. Jung HK, Son HY, Jung SA, et al. Comparison of oral omeprazole and endoscopic ethanol injection therapy for prevention of recurrent bleeding from peptic ulcers with nonbleeding visible vessels or fresh adherent clots. Am J Gastroenterol 2002; 97: 1736-40.
52. Lanas A, Artal A, Bias JM, Arroyo MT, Lopez-Zaborras J, Sainz R. Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer. J Clin Gastroenterol 1995; 21: 103-6.
53. Villanueva C, Balanzo J, Torras X, et al. Omeprazole versus ranitidine as adjunct therapy to endoscopic injection in actively bleeding ulcers: a prospective and randomized study. Endoscopy 1995; 27: 308-12.
54. Gisbert JP, Gonzalez L, Calvet X, Roque M, Gabriel R, Pajares JM. Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer. Aliment Pharmacol Ther 2001; 15: 917-26.
55. Zed PJ, Loewen PS, Slavik RS, Marra CA. Meta-analysis of proton pump inhibitors in treatment of bleeding peptic ulcers. Ann Pharmacother 2001; 35: 1528-34.
56. Leontiadis GI, McIntyre L, Sharma VK, Howden CW. Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev 2004: CD002094.
57. Sung JJ, Chan FK, Lau JY, et al. The effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots: a randomized comparison. Ann Intern Med 2003; 139: 237-43.
58. Khuroo M, Verma S. Gastric secretory pattern in normal subjects and duodenal ulcer patients in Kashmir. J Ind Med Assoc 1974; 63: 185-7.
59. Ahmed S, Khuroo MS, Ismail S. Minimal dose of histamine acid phosphate (H.A.P.) for maximal gastric acid secretion in subjects from Kashmir. J Assoc Physicians India 1975; 23: 321-5.
60. Daneshmend TK, Hawkey CJ, Langman MJ, Logan RF, Long RG, Walt RP. Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. BMJ 1992; 304: 143-7.
61. Barkun A, Martel M, Toubouti Y, Strazzulla J, Petit M. Is there a threshold PPI dose that decreases non lethal outcomes in patients with non variceal upper GI bleeding? Gastroenterology 2004; 126: W1275.
62. Barkun A, Racz I, van Rensburg C, et al. Prevention of peptic ulcer rebleeding using continuous infusion of pantoprazole vs. ranitidine: a multicenter, multinational, randomized, double-blind, parallel-group comparison. Gastroenterolgy 2004; 126: A-78.
63. Chang B, Waternaux C, Lipsitz S. Meta-analysis of binary data: which within study variance estimate to use? Stat Med 2001; 20: 1947-56.